225 related articles for article (PubMed ID: 15943846)
1. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
Otaka M; Jin M; Odashima M; Matsuhashi T; Wada I; Horikawa Y; Komatsu K; Ohba R; Oyake J; Hatakeyama N; Watanabe S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():42-6. PubMed ID: 15943846
[TBL] [Abstract][Full Text] [Related]
2. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia.
Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies.
Seno H; Nakase H; Chiba T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844
[TBL] [Abstract][Full Text] [Related]
4. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
7. [Serotonin 5- HT4 receptor agonist (mosapride citrate)].
Odaka T; Suzuki T; Seza A; Yamaguchi T; Saisho H
Nihon Rinsho; 2006 Aug; 64(8):1491-4. PubMed ID: 16898619
[TBL] [Abstract][Full Text] [Related]
8. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
Amarapurkar DN; Rane P
J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
11. Mosapride treatment for functional dyspepsia: a meta-analysis.
Bang CS; Kim JH; Baik GH; Kim HS; Park SH; Kim EJ; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ
J Gastroenterol Hepatol; 2015 Jan; 30(1):28-42. PubMed ID: 25041564
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
Sakurai K; Nagahara A; Inoue K; Akiyama J; Mabe K; Suzuki J; Habu Y; Araki A; Suzuki T; Satoh K; Nagami H; Harada R; Tano N; Kusaka M; Fujioka Y; Fujimura T; Shigeto N; Oumi T; Miwa J; Miwa H; Fujimoto K; Kinoshita Y; Haruma K
BMC Gastroenterol; 2012 May; 12():42. PubMed ID: 22548767
[TBL] [Abstract][Full Text] [Related]
14. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS).
Hongo M; Harasawa S; Mine T; Sasaki I; Matsueda K; Kusano M; Hanyu N; Nakada K; Shibata C
J Gastroenterol Hepatol; 2012 Jan; 27(1):62-8. PubMed ID: 22004457
[TBL] [Abstract][Full Text] [Related]
15. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.
Liu Z; Sakakibara R; Odaka T; Uchiyama T; Uchiyama T; Yamamoto T; Ito T; Asahina M; Yamaguchi K; Yamaguchi T; Hattori T
Mov Disord; 2005 Jun; 20(6):680-6. PubMed ID: 15719424
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia.
Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ
Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201
[TBL] [Abstract][Full Text] [Related]
18. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma.
Narita K; Tsunoda A; Takenaka K; Watanabe M; Nakao K; Kusano M
Dis Colon Rectum; 2008 Nov; 51(11):1692-5. PubMed ID: 18584249
[TBL] [Abstract][Full Text] [Related]
19. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia.
Mertz H; Fass R; Kodner A; Yan-Go F; Fullerton S; Mayer EA
Am J Gastroenterol; 1998 Feb; 93(2):160-5. PubMed ID: 9468233
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
